As part of Penn State Health’s commitment to innovation, Milton S. Hershey Medical Center offers a leading-edge procedure to repair parastomal hernias that reduces recurrences and improves patients’ quality of life.
The Spiration Valve SYSTEM and the Zephyr Valve, both available at Penn State Health Milton S. Hershey Medical Center, allow physicians to treat emphysema via innovative, minimally invasive procedures.
Continuing a trend of adding less invasive therapeutic options to its spine surgeons’ armamentarium, the Penn State Health Spine Center at Penn State Health Milton S. Hershey Medical Center now offers the OsteoCool RF Ablation System by Medtronic, a treatment that allows surgeons to palliate painful spinal metastases with radiofrequency (RF) ablation and stabilize the spine during the same procedure.
Prior to 2013, Penn State Children’s Hospital’s patients and families shared space with the adult hospital on the campus of Penn State Milton S. Hershey Medical Center. A three-story addition to the standalone Children’s Hospital that opened in 2013 — slated to be complete in November 2020 — will bring all children’s services into the Penn State Children’s Hospital, including a larger neonatal intensive care unit as well as the Labor and Delivery unit and postpartum patient rooms for women.
Hematology services within the Penn State Children’s Hospital’s Division of Pediatric Hematology and Oncology adds a key layer of expertise to the diagnosis and treatment of children with blood disorders.
The Penn State Health Spine Center at Penn State Health Milton S. Hershey Medical Center is transforming spine surgery in central Pennsylvania with the Mazor X Stealth Edition by Medtronic, a robotic guidance system that allows neurosurgeons to plan and execute open and minimally invasive spine surgeries with unprecedented accuracy, producing a bevy of benefits for patients.
Through pointed research efforts that aim to improve patient outcomes and quality of life, the Department of Neurosurgery at Penn State Health Milton S. Hershey Medical Center provides central Pennsylvania and surrounding counties with leading-edge surgical treatments for a variety of neurological conditions.
Colorectal cancer is the second-leading cause of cancer death in central Pennsylvania, which is partially attributable to low screening rates among certain segments of the population. Penn State Cancer Institute researchers are developing and testing strategies to improve screening rates in order to diagnose and treat colorectal cancer in earlier stages, when treatment efficacy is generally optimized.
True to its rich history of innovation, Penn State Heart and Vascular Institute at Penn State Health Milton S. Hershey Medical Center offers advanced therapies available only through clinical trials — treatments in the vanguard of care that can improve quality of life while laying the groundwork to help untold numbers of patients enjoy a brighter future.
Treatment of skull base tumors, including those affecting the pituitary gland, traditionally entailed opening the skull or making large incisions in the face and removing parts of the facial bones. These invasive procedures caused significant pain and scarring and required long hospital stays.